Propofol MCT Fresenius 20 mg/ml Fertigspritze, Emulsion zur Infusion in einer Fertigspritze
7680628740026
CH-62874
Fertigspritze
Associated product:
PROPOFOL 2% MCT Fresenius 1 g/50ml ser pré
1 / 3
google
Article details
- Package size
- 1 x 50 ml
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Fertigspritze
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
50.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.06 MG | Substance | HBESI |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 62874
- Drug name
- Propofol MCT Fresenius Fertigspritze, Emulsion zur Injektion/Infusion in einer Fertigspritze
- Galenic form
- EMIF
- ATC Code
- N01AX10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 23/09/2013
- Authorization expiration date
- 31/12/9999
- IT Number
- 01.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- PROPOFOL 2% MCT Fresenius 1 g/50ml ser pré
- Description (DE)
- PROPOFOL 2% MCT Fresenius 1 g/50ml Fertspr
- Market launch
- 23/09/2013
- Narcotic (BTM)
- No